Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
A-005 by Alumis for Multiple Sclerosis: Likelihood of Approval
A-005 is under clinical development by Alumis and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase I...
A-005 by Alumis for Parkinson's Disease: Likelihood of Approval
A-005 is under clinical development by Alumis and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase I...
A-005 by Alumis for Neurodegenerative Diseases: Likelihood of Approval
A-005 is under clinical development by Alumis and currently in Phase I for Neurodegenerative Diseases. According to GlobalData, Phase I...
A-005 by Alumis for Encephalomyelitis: Likelihood of Approval
A-005 is under clinical development by Alumis and currently in Phase I for Encephalomyelitis. According to GlobalData, Phase I drugs...